top border
top border
Featured Program
Treatment of Advanced Head & Neck Squamous Cell Carcinoma
Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.

Although most patients with differentiated thyroid cancer have an excellent prognosis, a subset of these patients will develop a more aggressive, refractory phenotype. This OncLive Peer Exchange moderated by R. Michael Tuttle, MD, focuses the latest information about how to use available therapies and the path forward to a more personalized approach for patients. The expert panel of endocrinologists and oncologists includes Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FACP, FACE; Eric J. Sherman, MD; and Francis Paul Worden, MD.
View Now
Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Kristi Rosa

Gina Columbus highlights the latest news from the 2019 ASH Annual Meeting in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x